BioTracker and Pulse4Pulse
Medical Tech Products and Devices
Newsome Park Strategies, in proud collaboration with our esteemed technology partners Pulse4Pulse and BioTracker is introducing two groundbreaking cardiovascular risk assessment screening tools poised to redefine the future of heart health and preventative medicine.
Both technologies represent the forefront of innovation and are united by a shared mission: to advance equity, early detection, and precision care by making powerful, non-invasive screening accessible to Primary Care Providers and the communities they serve.
We are equally committed to establishing both Pulse4Pulse and BioTracker as gold-standard technologies for assessing the heart, cardiovascular system, and autonomic nervous system delivering what we refer to as a comprehensive report card for the heart.
These screening systems FDA cleared, Medicaid and Medicare approved, and endorsed by respected health systems—equip providers with more than 150 data points covering over 50,000 miles of vascular tissue, enabling a level of insight that has never been available in primary care without a specialist referral.
The result is a clear, easy-to-understand, and actionable profile of each patient’s baseline heart health, sparking life-saving conversations, improving diagnostic confidence, and setting a higher standard of care in every clinical encounter.
More importantly, both tools can detect asymptomatic or hidden cardiovascular conditions and flag early warning signs long before symptoms surface. As such, they represent what we believe to be two of the most impactful and scalable preventative solutions in modern medicine.
By bringing these tools into minority, rural, and underserved communities, we are directly addressing the systemic inequities that contribute to higher rates of undetected heart disease and preventable cardiovascular events. These technologies don’t just detect disease, they empower proactive care, strengthen patient-provider relationships, and create a new culture of health accountability.
This is more than medical advancement—
It’s a transformational movement to reimagine how we combat the world’s leading cause of death.
With wider access to both Pulse4Pulse and BioTracker, more lives will be saved, more emergencies prevented, and more outcomes improved—on a national and global scale.
These are not just products.
This is a paradigm shift in preventative care, starting with the heart.
CEO
Medical Tech Products and Devices
Newsome Park Strategies, in proud collaboration with our esteemed technology partners Pulse4Pulse and BioTracker is introducing two groundbreaking cardiovascular risk assessment screening tools poised to redefine the future of heart health and preventative medicine.
Both technologies represent the forefront of innovation and are united by a shared mission: to advance equity, early detection, and precision care by making powerful, non-invasive screening accessible to Primary Care Providers and the communities they serve.
We are equally committed to establishing both Pulse4Pulse and BioTracker as gold-standard technologies for assessing the heart, cardiovascular system, and autonomic nervous system delivering what we refer to as a comprehensive report card for the heart.
These screening systems FDA cleared, Medicaid and Medicare approved, and endorsed by respected health systems—equip providers with more than 150 data points covering over 50,000 miles of vascular tissue, enabling a level of insight that has never been available in primary care without a specialist referral.
The result is a clear, easy-to-understand, and actionable profile of each patient’s baseline heart health, sparking life-saving conversations, improving diagnostic confidence, and setting a higher standard of care in every clinical encounter.
CEO
More importantly, both tools can detect asymptomatic or hidden cardiovascular conditions and flag early warning signs long before symptoms surface. As such, they represent what we believe to be two of the most impactful and scalable preventative solutions in modern medicine.
By bringing these tools into minority, rural, and underserved communities, we are directly addressing the systemic inequities that contribute to higher rates of undetected heart disease and preventable cardiovascular events. These technologies don’t just detect disease, they empower proactive care, strengthen patient-provider relationships, and create a new culture of health accountability.
This is more than medical advancement It’s a transformational movement to reimagine how we combat the world’s leading cause of death. With wider access to both Pulse4Pulse and BioTracker, more lives will be saved, more emergencies prevented, and more outcomes improved—on a national and global scale. These are not just products. This is a paradigm shift in preventative care, starting with the heart.
BioTracker and Pulse4Pulse
FDA Approved
- Non-Invasive
- 15 minute (In-Office)
- Autonomic, Vascular and Cardiovascular Risk Assessment
- Groundbreaking Preventative Screening technology.
Earlier Detection for Better Outcomes
THE PROBLEM
- Heart Disease is the main cause of DEATH in the world.
- 55.4 Million people in 2020 alone died from cardiovascular disease (CVD), with ischemic heart disease and stroke accounting for 17.9 million.......that 31% of those deaths
- 3 of 4 Patients who develop Peripheral Artery Disease (PAD) DO NOT SHOW SYMPTOMS
- Patients at highest risk for CVD are those with a history of Chronic Kidney Disease, Hypertension, Diabetes, excessive Alcohol use.
- Modifiable risk factors account for more than 70% of ALL CVD. This means that CVD can be reduced by disease prevention and early diagnosis.
PULSE4PULSE Diagnostic Testing
Our Mission
To empower Primary Care providers to Proactively Identify Cardiovascular and Peripheral Artery Disease indicators EARLIER, in even their asymptomatic patients. Earlier detection is made possible by our cutting-edge technology that focuses on the microvasculature, where diseases start.
NEW TOOL FOR DIAGNOSING HIDDEN ILLNESS
- Onsite diagnostic test
- 15 minute non-invasive
- Tests the cardiovascular and autonomic nervous system
- Administered by P4P medical technician
- 60% of patients qualify
NEW TOOL FOR DIAGNOSING HIDDEN ILLNESS
SUDOMOTOR TEST
- The device stimulates the patient's sweat glands by emitting a low voltage current through a glass plate.
- Results for this test helps the physician determine if the patient is going to be at risk of vascular disease or neuropathy.
AUTONOMIC NERVOUS SYSTEM TEST
- We report the heart- rate variability with beat-to-beat blood pressure in the patient after deep-breathing, head-tilt and Valsalva maneuver tests and compare to base-line.
- Many diseases of the nervous system identified.
ANKLE-BRACHIAL INDEX TEST
- A measurement of the ratio of blood pressure of the upper and lower body.
- Results indicate if the patient is suffering from vascular disease.
- Ability to test the vascular system at the micro-level.
HOW Pulse4Pulse and BioTracker WORKS
Patient comes into the practice for their regular appointment
Patient Completes Intake Form
Our medical technician conducts test
Results are immediately available for the Provider’s review
Patient follow-up visit scheduled
Practice receives all claims/remittances
P4P invoices per test
WHO QUALIFIES FOR SCREENING
Quick and easy reimbursement prequalification process. If the patient answers yes to any of these questions, they are cleared to receive the assessment. Results are compatible with all Electronic Medical Records systems and are made available to the practitioner in real time.
Why So Easy?
Payers realize and acknowledge that a preemptive screening, such as Pulse4Pulse and BioTracker, truly represents actuating Value-Based Medicine, reduces referrals to specialist and labs, promotes early detection and better outcomes. They also understand the cost savings associated with the aforementioned benefits.
REAL-TIME RESULTS AND RECOMMENDATIONS
- Turnkey wellness assessment service with $0 cost to practice.
- Instant, easy-to-interpret results with summary page extrapolated from the 3 simultaneous tests per the Pulse4Pulse and BioTracker algorithm.
- Identifies chronic diseases early to reduce invasive and costly interventions
BILLING OPTIONS
ACCEPTED BY MEDICARE, MEDICAID AND MOST MAJOR PRIVATE INSURANCE CARRIERS
Option 1
- Billing provided by Pulse4Pulse and BioTracker team on our national platform
- Established success working with insurance companies minimizing denials
Option 2
- Billing facilitated by the client through the individual practice with existing system
- Pulse4Pulse and BioTracker provides a billing liaison
BILLING DIAGNOSTIC CODES
There are 5 billing diagnostic codes approved by Medicare, Medicaid and most private payers up to 3 times per year
- Ankle Brachial Test (93923)
- Autonomic Function Test (95921)
- Sudomotor Test (95923)
- Electrocardiogram (93040)
- Pulse Oximetry (94761)
Additional Billing Code
- Follow-up Office Visit (99214)
Finances and Revenue-Fee for Service
- $0 start up cost
- $0 ongoing financial investment
- National average annual revenue increase of $150,000 net with one MD @ 5 patient screenings per day
- When a follow-up visit is included, the revenue increases to $160 -$170 per physician, per each patient screening
- *table includes follow up visit
